Wells Fargo
ENFN

Wells Fargo’s Enfusion, Inc. ENFN Stock Holding History

Wells Fargo’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26,380
Closed -$294K – 7452
2025
Q1 		$294K Buy
26,380
+881
+3% +$9.74K ﹤0.01% 4439
2024
Q4 		$263K Buy
25,499
+8,126
+47% +$78.5K ﹤0.01% 4621
2024
Q3 		$165K Sell
17,373
-192
-1% -$1.66K ﹤0.01% 4708
2024
Q2 		$150K Buy
17,565
+3,698
+27% +$33.8K ﹤0.01% 4693
2024
Q1 		$128K Buy
13,867
+2,146
+18% +$18.9K ﹤0.01% 4749
2023
Q4 		$114K Buy
11,721
+2,538
+28% +$23.7K ﹤0.01% 4823
2023
Q3 		$82.4K Sell
9,183
-5,431
-37% -$51.6K ﹤0.01% 4899
2023
Q2 		$164K Buy
14,614
+4,858
+50% +$43.1K ﹤0.01% 4707
2023
Q1 		$102K Buy
9,756
+2,833
+41% +$31.2K ﹤0.01% 4783
2022
Q4 		$66.9K Sell
6,923
-10,591
-60% -$119K ﹤0.01% 4735
2022
Q3 		$216K Sell
17,514
-308
-2% -$3.76K ﹤0.01% 4204
2022
Q2 		$182K Sell
17,822
-5,323
-23% -$58.8K ﹤0.01% 4332
2022
Q1 		$294K Sell
23,145
-8,811
-28% -$135K ﹤0.01% 4767
2021
Q4 		$669K Buy
+31,956
New +$646K ﹤0.01% 4436

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wells Fargo's ENFN Position: Q2 2025 in Review

Wells Fargo sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 26,380 shares — an estimated $294K sold.

Wells Fargo first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $669K in Q4 2021. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Wells Fargo reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Wells Fargo sold 26,380 Enfusion, Inc. shares in Q2 2025, an estimated $294K.
  • Wells Fargo first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
  • Wells Fargo's Enfusion, Inc. position peaked at $669K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Wells Fargo's 13F filing for Q2 2025, filed 14 Aug 2025.